leadf
logo-loader
viewIMV Inc

IMV advancing its potential immune-boosting coronavirus vaccine

IMV Inc. (NASDAQ:IMV) (TSE:IMV) CEO Frederic Ors tells Proactive the Canadian biotechnology company is at the validation stage of advancing its vaccine candidate to help prevent the coronavirus.

Ors explains how the biotech, which has experience carrying out clinical trials in oncology, is developing a vaccine that is unique to its peers'.

Quick facts: IMV Inc

Price: 3.47 USD

NASDAQ:IMV
Market: NASDAQ
Market Cap: $232.81 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold identifies new high-grade zone north of Medusa at Cuiu Cuiu...

Cabral Gold (CVER: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive with news drilling on the Cuiu Cuiu projects has turned up another high-grade zone. Carter telling Proactive about this new zone located North of the Medusa Target. He also told Proactive about a new drill...

30 minutes ago

2 min read